ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Schmidt Has Doubts About Community Saturation Program; Diane Fink Wins Gerard Lambert Award

July 25, 1975

Major League Baseball Begins Struggle to Eject Ever-Present Smokeless Tobacco Forom The Sport

April 12, 1991

Mammography’s Best Role Is Screening, Kopans Assert

March 18, 1994

House panel gives NIH 0.5 percent increase, matching the President’s budget request.

June 17, 2005

Beefed Up Centers Subcommittee Meets On Core Guidelines

December 2, 1977

NCI To Spend About $150 Mil. On Cancers That Affect Only Women

April 26, 1991